Today at the International Conference on HIV/AIDS in Melbourne activists held a protest in response to the presentation of Sofosbuvir, Gilead’s new hepatitis C virus (HCV) drug. The price of one course’s treatment with this drug will be 80 000 EUR, what
[…]